Peroxiredoxin 6 overexpression regulates adriamycin-induced myocardial injury, oxidative stress and immune response in rats

BACKGROUND: Adriamycin is an anthracycline drug used to treat a variety of tumors. Adriamycin has a much stronger affinity for myocardial tissue than other body tissues. Cancer patients treated with adriamycin are prone to toxic damage to heart tissue. Peroxiredoxin 6 (PRDX6) is a novel antioxidant...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jianshu, Cao, Weiping, Chen, Chi, Chen, Xiaohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661857/
https://www.ncbi.nlm.nih.gov/pubmed/33209900
http://dx.doi.org/10.21037/atm-20-6598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661857/
https://www.ncbi.nlm.nih.gov/pubmed/33209900
http://dx.doi.org/10.21037/atm-20-6598

Ejemplares similares